ProQR Therapeutics N.V.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of ProQR Therapeutics N.V. generated cash of $21,548,000, which is more than the previous year. Cash used in financing activities reached the amount of -$2,275,000 last year. Net change in cash is therefore $24,150,000.
Cash Flow
| 2014 | -14.45M | -1.23M | 119.88M |
|---|---|---|---|
| 2015 | -24.23M | -1.32M | 1.62M |
| 2016 | -34.22M | -2.53M | 357K |
| 2017 | -34.95M | -121K | 26.64M |
| 2018 | -30.68M | -312K | 88.64M |
| 2019 | -43.97M | -580K | 50.19M |
| 2020 | -47.06M | -924K | 14.5M |
| 2021 | -26.01M | -425K | 136.83M |
| 2022 | -68.50M | -702K | -30.89M |
| 2023 | 21.54M | 4.27M | -2.27M |
PRQR Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 94.77M | 187.52M | 75.83M | 111.95M | 105.58M | 48.09M | 59.2M | 94.86M | 112.73M | 4.12M |
Operating activities | ||||||||||
Net income | -27.54M | -64.89M | -61.68M | -46.61M | -56.74M | -37.08M | -43.52M | -39.11M | -20.83M | -12.12M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.46M | 2.52M | 2.32M | 2.35M | 2.05M | 992K | 1.06M | 1.24M | 480K | 126K |
Stock-based compensation expense | 3.10M | 2.86M | 6.21M | 7.83M | 9.10M | 0 | 4.02M | 2.45M | 1.21M | 646K |
| Deferred income tax benefit | 3.10M | 2.86M | 6.21M | 7.83M | 9.10M | 0 | 4.02M | 2.45M | 1.21M | 646K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 21.54M | -68.50M | -26.01M | -47.06M | -43.97M | -30.68M | -34.95M | -34.22M | -24.23M | -14.45M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -3.64M | -708K | -484K | -924K | -580K | -312K | -121K | -2.53M | -1.32M | -1.23M |
Acquisitions Net | 58.77K | 5.89K | 61.35K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 4.27M | -702K | -425K | -924K | -580K | -312K | -121K | -2.53M | -1.32M | -1.23M |
Financing activities | ||||||||||
Common Stock Issued | 346.74K | 14.12M | 108.47M | 684.79K | 48.55M | 86.38M | 25.68M | 0 | 14.29K | 118.25M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -2.62M | -45.04M | -820K | -605K | 1.45M | 0 | 951K | -15K | 1.60M | -34K |
Cash used in financing activities | -2.27M | -30.89M | 136.83M | 14.5M | 50.19M | 88.64M | 26.64M | 357K | 1.62M | 119.88M |
Net Change In Cash | 24.15M | -92.74M | 111.68M | -36.11M | 6.37M | 57.48M | -11.10M | -35.66M | -17.87M | 108.60M |
Cash at end of period | 118.92M | 94.77M | 187.52M | 75.83M | 111.95M | 105.58M | 48.09M | 59.2M | 94.86M | 112.73M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |